These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9094751)

  • 1. The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system.
    Polley JS; Gaskin PJ; Perren MJ; Connor HE; Ward P; Beattie DT
    Regul Pept; 1997 Jan; 68(1):23-9. PubMed ID: 9094751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
    Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
    Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig.
    Clayton JS; Gaskin PJ; Beattie DT
    Brain Res; 1997 Nov; 775(1-2):74-80. PubMed ID: 9439830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation.
    Goadsby PJ; Hoskin KL; Knight YE
    Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.
    Shepheard SL; Williamson DJ; Williams J; Hill RG; Hargreaves RJ
    Neuropharmacology; 1995 Mar; 34(3):255-61. PubMed ID: 7630480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater.
    O'Shaughnessy CT; Connor HE
    Eur J Pharmacol; 1994 Sep; 263(1-2):193-8. PubMed ID: 7821352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.
    Lee WS; Moussaoui SM; Moskowitz MA
    Br J Pharmacol; 1994 Jul; 112(3):920-4. PubMed ID: 7921621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea-pigs.
    Beattie DT; Connor HE
    Br J Pharmacol; 1994 May; 112(1):262-6. PubMed ID: 8032648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat.
    Bereiter DA; Bereiter DF; Tonnessen BH; Maclean DB
    Neuroscience; 1998 Mar; 83(2):525-34. PubMed ID: 9460760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist.
    Hutson PH; Patel S; Jay MT; Barton CL
    Eur J Pharmacol; 2004 Jan; 484(1):57-64. PubMed ID: 14729382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist.
    Grélot L; Dapzol J; Estève E; Frugière A; Bianchi AL; Sheldrick RL; Gardner CJ; Ward P
    Br J Pharmacol; 1998 Aug; 124(8):1643-50. PubMed ID: 9756379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.
    Cutrer FM; Moussaoui S; Garret C; Moskowitz MA
    Neuroscience; 1995 Feb; 64(3):741-50. PubMed ID: 7536309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
    Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
    Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.
    Emonds-Alt X; Doutremepuich JD; Heaulme M; Neliat G; Santucci V; Steinberg R; Vilain P; Bichon D; Ducoux JP; Proietto V
    Eur J Pharmacol; 1993 Dec; 250(3):403-13. PubMed ID: 7509286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions.
    McAllister KH; Pratt JA
    Eur J Pharmacol; 1998 Jul; 353(2-3):141-8. PubMed ID: 9726644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs.
    Fukuda H; Koga T; Furukawa N; Nakamura E; Shiroshita Y
    Neurosci Res; 1999 Jan; 33(1):25-32. PubMed ID: 10096468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
    Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
    Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats.
    Cumberbatch MJ; Carlson E; Wyatt A; Boyce S; Hill RG; Rupniak NM
    Neuropharmacology; 1998 Dec; 37(12):1535-43. PubMed ID: 9886676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tachykinin NK1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs.
    Fukuda H; Koga T; Furukawa N; Nakamura E; Shiroshita Y
    Brain Res; 1998 Aug; 802(1-2):221-31. PubMed ID: 9748589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.